"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
| Descriptor ID |
D018426
|
| MeSH Number(s) |
E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
|
| Concept/Terms |
SEER Program- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
|
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 2 | 4 |
| 2008 | 1 | 3 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 1 | 7 | 8 |
| 2011 | 1 | 8 | 9 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 13 | 13 |
| 2014 | 2 | 17 | 19 |
| 2015 | 1 | 9 | 10 |
| 2016 | 0 | 12 | 12 |
| 2017 | 1 | 6 | 7 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 13 | 13 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
-
Health insurance continuity and mortality in children, adolescents, and young adults with blood cancer. J Natl Cancer Inst. 2025 Feb 01; 117(2):344-354.
-
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults. Blood Adv. 2025 Jan 28; 9(2):280-290.
-
Survival Outcomes of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database: Comparison with Radiotherapy and Resection. J Vasc Interv Radiol. 2025 Mar; 36(3):489-498.e3.
-
Survival outcomes and molecular drivers of testicular cancer in hispanic men. Urol Oncol. 2024 Sep; 42(9):293.e1-293.e7.
-
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Jul; 25(5):440-448.
-
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy. J Thorac Cardiovasc Surg. 2024 Oct; 168(4):1261-1269.e1.
-
Inflammatory Tongue Conditions and Risk of Oral Tongue Cancer Among the US Elderly Individuals. J Clin Oncol. 2024 May 20; 42(15):1745-1753.
-
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016. Medicine (Baltimore). 2022 Mar 18; 101(11).
-
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data. PLoS One. 2022; 17(3):e0265543.
-
Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.